Paul Anderson
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Paul Anderson
Founder, Managing Director / Orthocell
Most Notable Role
Paul Anderson has over 20 years of experience in the medical device and cellular therapeutic fields, with expertise in bridging the gap between research and clinical practice in the development of emerging medical technologies.
Mr Anderson has held board and chief executive positions with a human cell therapies company.
Mr Anderson has held board and chief executive positions with a human cell therapies company.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 91st | Botanix Pharmaceuticals | 100% | 43% |
| 516th | Orthocell | 10% | 27% |
| 536th | Proteomics International Laboratories | 8% | 26% |
| 1095th | Adisyn | -25% | |
| 1612th | Nuheara | -60% | -44% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 124th |  | Orthocell | $4.3m |
| 131st |  | Nuheara | $3.8m |
| 132nd | | Botanix Pharmaceuticals | $3.8m |
| 136th | | Proteomics International Laboratories | $3.2m |
| 137th | | Adisyn | $2.9m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in US approval for Orthocell regeneration product | 14 Jan 2021 |
| REMUNERATION UPDATE: Founder, Managing Director, Orthocell | 02 Nov 2020 |
| REMUNERATION UPDATE: Founder, Managing Director, Orthocell | 24 Aug 2020 |
| REMUNERATION UPDATE: Founder, Managing Director, Orthocell | 30 Jun 2020 |
